Zai Lab

$181.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.47 (-0.26%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Zai Lab and other stocks, options, and ETFs commission-free!

About ZLAB

Zai Lab Limited American Depositary Shares, also called Zai Lab, is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious and autoimmune diseases. The company's products include Zejula and Optune. Zai Lab was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China. The listed name for ZLAB is Zai Lab Limited American Depositary Shares.

CEO

Ying Samantha Du

Employees

692

Headquarters

Shanghai, Shanghai

Founded

2014

Market Cap

16.43B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

470.34K

High Today

$187.40

Low Today

$180.24

Open Price

$182.23

Volume

266.64K

52 Week High

$193.54

52 Week Low

$43.06

Collections

Analyst Ratings

91%

of 11 ratings

Buy

91%

Hold

Sell

ZLAB Earnings

-$1.37

-$0.91

-$0.46

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 5, Pre-Market